Consolidated and per-location reporting
The group view and the store view come out of the same close, on the same definitions, so comparing location three to location one means something.
Multi-location pharmacies
Grow on purpose, with numbers that prove it.
You built a group. The reporting, the tax plan, and the structure should be as deliberate as the expansion was.
Per store P&L
Month to dateMain Street$412,870
Net margin6.4%
Lakeside$318,450
Net margin5.1%
Northgate$275,310
Net margin7.8%
Payer mix
Trailing 90 daysCommercial38%
Medicare D31%
Medicaid18%
Cash13%
Where we focus
Tax strategy, consolidation, real estate, compounding.
Four places where multi-location groups gain the most, fastest.
Tax planning and strategy
Entity structure, reasonable compensation, timing of major spend, and multi-state exposure planned quarterly rather than discovered at filing.
Real estate you own
Self-rental treatment, holding company structure, and cost segregation on the buildings that justify a study. This is where most groups are leaving real money behind.
Acquisition and expansion
Quality of earnings, inventory verification, financing scenarios, and an integration plan so store four does not break the reporting you just fixed.
Multi-state operations
Payroll, licensing, and inventory rules change at every state line. We keep the compliance calendar and the ledger in agreement.
A close that takes days, not weeks
Automated coding, matched reconciliations, and a standing checklist replace the three-week consolidation your bookkeeper dreads.
Compounding
Margin per compound, not margin in aggregate.
Compounders built expensive sterile facilities and run a genuinely different cost structure. Batch costing, labor per preparation, waste, and compliance costs deserve their own accounting.
- Cost per preparation built from ingredients, labor, and overhead
- Compliance and facility costs tracked as their own line, not buried in overhead
- Pricing reviews grounded in what each compound actually earns
- Compounding reported separately from retail so neither hides the other
Margin per compound
Cost accountedSterile IV$68.40
Hormone$44.10
Derm base$27.85
Per store P&L
Month to dateMain Street$412,870
Net margin6.4%
Lakeside$318,450
Net margin5.1%
Northgate$275,310
Net margin7.8%
Fluency
We speak pharmacy, fluently.
The systems, buying groups, PSAOs, and PBMs we work in every day. Not logos on a wall, the software we are already inside of before your first close.
POS and pharmacy systems
- PioneerRx
- Rx30
- ComputerRx
- Liberty
- BestRx
- QS/1
Buying groups
- AAP
- IPC
- EPIC Rx
PSAOs
- AlignRx
- Elevate Provider Network
- EPIC Pharmacy Network
PBMs
- CVS Caremark
- Express Scripts
- Optum Rx
- Prime Therapeutics
- MedImpact
All names and marks belong to their respective owners. Listing a system, buying group, PSAO, or PBM means we work in it. It does not imply partnership or endorsement.
Reporting is the foundation either way.
Tax strategy, acquisitions, and real estate decisions all rest on the same thing: a close you trust and reports you can read. That is where every engagement starts.